Chi‐Long Chen
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 8
- Oncology top 5%
- Viral-associated cancers and disorders 13
- Cancer-related Molecular Pathways 7
-
- Genetic factors in colorectal cancer 6
- Lymphoma Diagnosis and Treatment 6
- Molecular Biology top 5%
- Cancer-related gene regulation 9
- RNA modifications and cancer 7
- Otorhinolaryngology top 5%
-
- Glioma Diagnosis and Treatment 5
- Co-authors
- Michael HsiaoYu‐Chan ChangChih‐Yeu FangYung‐Ming JengAnn‐Lii ChengChia‐Yi SuTai‐I HsuYuan‐Feng Lin
- Partner nations
- TaiwanUnited StatesHong Kong
In The Last Decade
Chi‐Long Chen
104 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 680
- Oncology 910
- Pathology and Forensic Medicine 346
- Molecular Biology 1.3k
- Otorhinolaryngology 72
Countries citing papers authored by Chi‐Long Chen
This map shows the geographic impact of Chi‐Long Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Long Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Long Chen more than expected).
Fields of papers citing papers by Chi‐Long Chen
This network shows the impact of papers produced by Chi‐Long Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Long Chen. The network helps show where Chi‐Long Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chi‐Long Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 3 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 15 | |
| 11 | 2017 | 10 | |
| 12 | 2016 | 41 | |
| 13 | 2014 | 91 | |
| 14 | 2010 | 17 | |
| 15 | 2009 | 36 | |
| 16 | 2009 | 66 | |
| 17 | 2006 | 197 | |
| 18 | 2001 | 58 | |
| 19 | 1996 | 5 | |
| 20 | 1989 | 9 |
About Chi‐Long Chen
Chi‐Long Chen is a scholar working on Oncology, Cancer Research, Genetics, Pathology and Forensic Medicine and Immunology, having authored 106 papers that have together received 2.9k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (13 papers), Cancer-related gene regulation (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (7 papers), Genetic factors in colorectal cancer (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (680 citations), Oncology (910 citations), Pathology and Forensic Medicine (346 citations), Molecular Biology (1.3k citations) and Otorhinolaryngology (72 citations). Chi‐Long Chen has collaborated with scholars based in Taiwan, United States and Hong Kong. Frequent co-authors include Michael Hsiao, Yu‐Chan Chang, Chih‐Yeu Fang, Yung‐Ming Jeng, Ann‐Lii Cheng, Chia‐Yi Su, Tai‐I Hsu, Yuan‐Feng Lin, Ching‐Hwa Tsai and Chuen Hsueh. Their work appears in journals such as PLoS ONE, Oncotarget, Cancers, Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.